The 130th Annual Meeting of APHA

3109.0: Monday, November 11, 2002 - Table 7

Abstract #36827

Development, use, and evaluation of an assessment tool for an HIV maternal-to-child transmission reduction program

Molly A. Rose, PhD1, Mary Schaal, RN, EdD1, and Ann Doherty, RN, JD, PhD2. (1) College of Health Professions, Department of Nursing, Thomas Jefferson University, 130 S. 9th Street Suite 1215, Philadelphia, PA 19107, 215-503-7567, Molly.Rose@mail.tju.edu, (2) Catholic Medical Mission Board, 10 W. 17th Street, New York City, NY 10011

An interdisciplinary team of nurses and doctors recently visited South Africa to assess the capacity of several established clinics to implement a nevirapine program to reduce the maternal-to-child transmission of HIV/AIDS. With a total of 4.2 million infected people (2.3 million of whom are women), South Africa has the largest number of people living with AIDS. After reviewing the literature, an assessment tool relevant to this project could not be located. The Centers for Disease Control and Prevention’s public health infrastructure model [public health response emerging infections (AIDS), 1999] was used as the framework for development of an appropriate assessment tool. The three components of the basic public health infrastructure (workforce capacity and competency, information and data systems, and organizational capacity) and the three components of the essential capacities (surveillance, laboratory practice, and epidemic investigation) served to guide the development of the assessment tool. The tool served as the mechanism to assess seven clinics throughout South Africa. The tool development, guiding questions, implementation, and evaluation of the tool will be discussed. A brief overview of the findings will be presented with recommendations for future tool implementation.

Learning Objectives:

  • At the completion of the session, participants will be able to

    Presenting author's disclosure statement:
    I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

    Factors Affecting HIV Risk Behaviors and Treatment Adherence

    The 130th Annual Meeting of APHA